Drug Information

Drug General Information
Drug ID
D0N7WG
Former ID
DCL000038
Drug Name
AM-111
Indication Neurological disease [ICD9: 338, 338.2, 410, 782.3,780; ICD10:I21, I22, R52, R52.1-R52.2, R60.9, G89] Phase 3 [524909]
Company
Auris Medical
Structure
Download
2D MOL
Formula
C164H285N65O41
PubChem Compound ID
72941992
Target and Pathway
Target(s) Jun N terminal kinase Target Info Modulator
References
Ref 524909ClinicalTrials.gov (NCT02235272) Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.